Independent Shareholders Advocate for Dividend Payment
Stakeholders of Sinovac Biotech Ltd. (NASDAQ: SVA) are demonstrating remarkable unity in requesting the prompt payment of a $19.00 dividend. This dividend was declared previously and is seen as an essential financial right for independent shareholders.
Impact of Trading Suspension
Since 2019, trading of Sinovac's stock has been suspended, depriving shareholders of potential gains from the company's successful COVID-19 vaccine, CoronaVac. As a result, shareholders missed significant returns during a period when the company achieved substantial sales during the pandemic.
Previous Dividend Compensation
In July 2025, the company’s current board made the decision to issue a $55.00 dividend, acknowledging the dividends that were not distributed to shareholders during the trading suspension. This amount was a partial compensation aimed at addressing investor concerns and restoring confidence.
Recent Dividend Declaration
On June 17, 2025, the board proposed yet another dividend of $19.00. This recent announcement reflects their ongoing commitment to recompensing independent shareholders who were previously overlooked while certain insiders received dividends from subsidiaries.
Awaiting Payment Confirmation
Despite the previous announcements, shareholders have yet to receive any information on record and payment dates for the declared dividend, leaving many in suspense. This delay is particularly surprising because both the current board and a consortium vying for board replacement had pledged to prioritize shareholder dividends.
The Call for Action
Prominent figures within the shareholder community, including Peter Halesworth of Heng Ren Silk Road Investments LLC, have emphasized the necessity for transparency and action from the board. Halesworth stated, "Decision-makers involved in Sinovac must acknowledge and act on the clear and overwhelming support from independent shareholders regarding dividend payments." The urgency for the board to establish clear payment dates for the promised $19.00 dividend is apparent.
Looking Ahead
Heng Ren Silk Road Investments LLC is actively promoting a campaign centered on shareholder fairness, underscoring their commitment to advocate for independent shareholders. Upcoming webinars will provide shareholders with additional insights into the voting process and the ongoing matters that require attention. Participants are encouraged to engage and bring their queries to these discussions.
Media and Contact Information
The campaign led by Heng Ren aims to foster an informed community of shareholders. Media inquiries can be directed to Peter Halesworth, Founder & CIO of Heng Ren Silk Road Investments LLC, through email at info@hengreninvestment.com.
Frequently Asked Questions
What is the recent dividend declared by Sinovac?
The board has declared a dividend of $19.00 per common share as a part of their effort to compensate independent shareholders.
Why has Sinovac's trading been halted?
Sinovac's trading has been paused since 2019, which has limited shareholders' access to potential gains from their investments.
How much was the previous dividend paid in July 2025?
The board paid a dividend of $55.00 to shareholders in July 2025 as compensation for unpaid dividends during the trading halt.
When is the payment expected for the declared $19.00 dividend?
As of now, Sinovac has not provided any record and payment dates for the declared dividend.
Who can shareholders reach out to for more information?
Shareholders can reach out to Peter Halesworth at Heng Ren Silk Road Investments LLC for more information and inquiries.
